Angiotensin II mediates the axonal trafficking of tyrosine hydroxylase and dopamine β‐hydroxylase mRNAs and enhances norepinephrine synthesis in primary sympathetic neurons. Issue 6 (31st July 2019)

• Record Type: Journal Article
• Authors: Aschrafi, Armaz; Berndt, Adama; Kowalak, Jeffrey A.; Gale, Jenna R.; Gioio, Anthony E.; Kaplan, Barry B.
• Is Part Of: Journal of neurochemistry. Volume 150:Issue 6(2019)
• Page Start: 666
• Page End: 677
• Publication Date: 2019-07-31
• Subjects: axon -- catecholamine -- mRNA trafficking -- superior cervical ganglia neurons -- sympathetic nervous system -- tyrosine hydroxylase; Neurochemistry -- Periodicals; 616.8042
• DOI: 10.1111/jnc.14821
• Languages: English
• ISSNs: 0022-3042

Abstract

Abstract: In the sympatho‐adrenal system, angiotensin II (Ang II) acts as a key neuromodulatory component. At sympathetic nerve terminals, Ang II influences sympathetic transmission by enhancing norepinephrine (NE) synthesis, facilitating NE release and inhibiting NE uptake. Previously, it was demonstrated that tyrosine hydroxylase (TH) mRNA is trafficked to the distal axons of primary superior cervical ganglia (SCG) neurons, directed by a cis ‐acting regulatory element (i.e. zipcode) located in the 3'UTR of the transcript. Results of metabolic labeling studies established that the mRNA is locally translated. It was further shown that the axonal trafficking of the mRNA encoding the enzyme plays an important role in mediating dopamine (DA) and NE synthesis and may facilitate the maintenance of axonal catecholamine levels. In the present study, the hypothesis was tested that Ang II induces NE synthesis in rat primary SCG neurons via the modulation of the trafficking of the mRNAs encoding the catecholamine synthesizing enzymes TH and dopamine β‐hydroxylase (DBH). Treatment of SCG neurons with the Ang II receptor type 1 (AT1R) agonist, L‐162, 313, increases the axonal levels of TH and DBH mRNA and protein and results in elevated NE levels. Conversely, treatment of rat SCG neurons with the AT1R antagonist, Eprosartan, abolished the L‐162, 313‐mediated increase in axonal levels of TH and DBH mRNA and protein. In a first attempt to identify the proteins involved in the Ang II‐mediated axonal transport of TH mRNA, we used a biotinylated 50‐nucleotide TH RNA zipcode as bait in the affinity purification of TH zipcode‐associated proteins. Mass spectrometric analysis of the TH zipcode ribonucleoprotein (RNP) complex immune‐purified from SCG neurons led to the identification of 163 somal and 127 axonal proteins functionally involved in binding nucleic acids, the translational machinery or acting as subunits of cytoskeletal and motor proteins. Surprisingly, immune‐purification of the TH axonal trafficking complex, results in the acquisition of DBH mRNA, suggesting that these mRNAs maybe transported to the axon together, possibly in the same RNP complex. Taken together, our results point to a novel mechanism by which Ang II participates in the regulation of axonal synthesis of NE by modulating the local trafficking and expression of TH and DBH, two key enzymes involved in the catecholamine biosynthetic pathway. Abstract : Angiotensin II (Ang II) acts as a key neuromodulatory component, influencing sympathetic transmission by enhancing norepinephrine (NE) synthesis and facilitating NE release. Here, we tested the hypothesis that Ang II regulates the axonal levels of the mRNAs encoding tyrosine hydroxylase (TH) and Dopamine β‐Hydroxylase (DBH), resulting in the modulation of catecholamine synthesis in sympathetic neurons. The outcome of our studies demonstrates that treatment of superior cervical ganglia (SCG) neurons with a selective Ang II agonist increases the axonal levels of TH and DBH mRNA and protein and results in elevated presynaptic NE synthesis and release in primary rat sympathetic neurons.